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Thirty-six plant extracts from the brazilian Atlantic Forest were
tested for their antimycobacterial activity against Mycobacterium
tuberculosis H37Rv and M. kansasii, using the method REMA in
seriate concentrations of 100 to 0.20 µg/mL. Among the thirty
six extracts tested, five were active against M. tuberculosis, and
three of these extracts also showed activity against M. kansasii.
Cytotoxicity test with VERO cells was performed with the five
extracts active against M. tuberculosis. Only the extract of
Peschiera affinis was identified as non-toxic in the concentration
of 100µg/mL.
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Tuberculosis (TB) is considered one of the main cau-
ses of death worldwide. There were nine million new TB ca-
ses and approximately two million TB deaths in 2004
(WHO, 2006). The available treatment requires a long
lasting (at least six months) multi-drug scheme, which cau-
ses difficulties to the patient’s adhesion. Furthermore the
available drugs do not assure the sterilization of the lesion,
being possible that, in spite of the clinical cure the bacillus
stays in latent state inside the macrophages. Associated to
these factors is the increase of the number of cases of TB
with resistant and multi-drug resistant (MDR) strains and
the insufficient therapeutic arsenal available for the
treatment, which stimulates the development of new anti-
TB drugs (Silva et al., 2006).
In addition to that, some species of non-tuberculous
mycobacteria (NTM) have increased their clinical
importance in the last years. M. kansasii causes both
pulmonary and extra-pulmonary diseases and ranked
second behind Mycobacterium avium complex as the most
common MNT infections (Graybill, Bocanegra, 2001;
Telles et al., 2005). The current treatment of pulmonary
diseases caused by M. kansasii in non-HIV-infected
patients includes isoniazid, rifampicin and ethambutol.
Nevertheless, alternative drugs have been proposed for
patients infected with M. kansasii resistant to rifampicin
and AIDS patients treated with HIV protease inhibitors,
since rifampicin accelerates the hepatic metabolism of these
drugs, rendering them potentially ineffective (Guna et al.,
2005).
Since ancient times, natural products notably those
from plant origin, have consistently been an important
source of therapeutic agents. Currently, about 25-30% of
all drugs available as therapeutics are derived from natu-
ral products (plants, microbes and animals). In spite of that,
in the last decades, due mainly to the advance of
combinatorial chemistry, research into natural products in
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the pharmaceutical industry has experienced a slow decli-
ne (Calixto, 2005; Newman et al., 2003). The search for
new pharmacologically active agents obtained by screening
natural sources such as microbial and plant extracts has led
to the discovery of many clinical useful drugs that play a
major role in the treatment of human diseases (Shu, 1998).
Several compounds with antimycobacterial activity
have been found among plants, fungi and marine organisms
(Lewis, 1999; Pauli et al., 2005). Over 350 natural
products, mainly plant species, which have been used in
traditional medicine, have been assessed for their
antimycobacterial activities (Newton et al., 2000). A
number have been shown to demonstrate significant in vitro
antimycobacterial activities and active plant-derived
compounds belonging to various chemical classes have
been isolated. These findings have therefore stimulated
further search towards the isolation of new
antimycobacterial agents from natural products (Newton et
al., 2002). This products form one avenue in the search for
new antitubercular agents, with many groups undertaking
screening of natural product extracts as the preliminary
step to finding new lead compounds, as for combinations of
cost, health and throughput issues, there are a wide range
of mycobacterial test organisms and biological assay
methodologies utilized in current day antimycobacterial
drug discovery (Copp, 2003).
Likewise, different kinds of studies on the
mechanisms of action, interactions with antibiotics or other
medicinal plants or compounds, and the pharmacokinetic
profile of the extracts should be given high priority (Ríos,
Recio, 2005).
Natural products chemistry is a research area with
unlimited potential, important to countries rich in plant
species and which are abundant in native vegetation like
Brazil. This country is one of the two richest countries on
earth in terms of biodiversity and has two of the 25 world’s
hotspots threatened of disappear (Mittermeier et al., 1998).
The Atlantic Forest region ranks among the top five of these
hotspots and only 7.5% of the original extent of the Atlantic
Forest remain intact. Given the fast devastation of the
environment the screening of plant secondary metabolites
for the search of biological activities becomes an urgent
task (Calixto, 2005).
In this study we evaluated the antimycobacterial
activity of 36 plant extracts belonging to 19 different
botanical families (Anacardiaceae, Apocynaceae,
Bignoniaceae, Bombacaceae, Caesalpiniaceae,
Euphorbiaceae, Fabaceae, Flacourtiaceae, Lecythidaceae,
Mimosaceae, Meliaceae, Moraceae, Myristicaceae,
Nyctaginaceae, Rubiaceae, Rutaceae, Sapotaceae,
Siparunaceae, Tiliaceae) selected from the Atlantic Forest.
MATERIALS AND METHODS
Plant material
Plants were collected from two Atlantic Forest
fragments (Bela Fama Forest - Santana do Deserto city,
MG and Boa Vista Forest - Levy Gasparian city, RJ),
Brazil. Taxonomic identifications were done by Sebastião
J. da Silva Neto from Instituto de Pesquisas Jardim Botâ-
nico do Rio de Janeiro, Brazil. Voucher specimens are
deposited at the Herbarium of the Federal University of Rio
de Janeiro.
Preparation of extracts
The air-dried and powdered leaves (20 g of each)
were exhaustively extracted with ethanol 96° GL. The
obtained extracts were filtered and evaporated under
reduced pressure on a rotary evaporator.
Isolates and strain preparation
The antimicrobial activity of the extracts was
evaluated against M. tuberculosis H37Rv (ATCC 27294)
and M. kansasii (ATCC 12478) maintained on Ogawa
medium for about 14 days. The bacterial suspensions were
prepared in sterile water containing beads of glass of 3 mm.
The suspension was homogenized by vortex agitation and
the turbidity was adjusted in agreement with tube one of the
scale of McFarland (3,2 x 106 cfu/mL). The inoculum was
prepared diluting the bacterial suspension in the proportion
of 1:25 in medium 7H9 broth (4.7 g of Middlebrook 7H9
broth base [Difco - Becton Diskinson], 2 mL of glycerol
[Vetec ltda.] in 900 ml water) enriched with 10% oleic acid,
albumin, dextrose and catalase (OADC -BBL) (Franzblau
et al., 1998).
Evaluation of the antimycobacterial activity of the
extracts
The method used for the determination of the
antimycobacterial activity was the REMA (Palomino et al.,
2002). The screening assay was, in brief, accomplished in
microplates (96 wells) using the resazurin as indicator of
cellular viability. Seventy-five microlitres of medium 7H9
enriched with 10% OADC was used in each well, after was
added 75 µL of the extracts were weighted dissolved in
DMSO at a concentration of 100 µg/mL and 75 µL of the
Mycobacterium inoculum. The Minimal Inhibitory
Concentration (MIC) was determined for extract serial
dilutions (starting for 100 µg/mL) using 100 µL of medium
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7H9, 100 µL of extract and 100 µL of inoculum. The MIC
was did just for those extracts presenting antimycobacterial
activity at 100 µg/mL in the screening assay. We establish
MIC 100 µg/mL as active because the MIC of a crude na-
tural extract may or may not be a reliable indicator of the
chances for success in isolating a potent antimycobacterial
agent from that extract. The possibility exists that (i) an
extract with a relatively low MIC (high activity) may
contain large quantities of only very few moderately active
major constituents, while (ii) moderately active crude
materials could lead to minor compounds with high activity
(Pauli et al., 2005).
Cytotoxicity assay
The citototoxicity of the extracts with
antimycobacterial activity were determined with VERO
cells (Case et al., 2006). Concisely, the VERO cells were
cultivated at 37 ºC in a humid atmosphere with 5% CO2
(Sánchez et al., 2002) in modified DMEM medium (10,4 g
DMEM, 900 ml water MilliQ, 2,0g NaHCO3 - Sigma
D5671) complemented with 10% Bovine Fetal Serum
(FCS), in order to obtain about 1 to 2x105 cell/mL
(Sivropoulou et al., 1997). The extracts were serial diluted
(1:2) from an initial concentration of 100µg/ml to a final
concentration of 3µg/mL. The number of cells was
determined in a Neubauer’s chamber, while the percentage
of viable cells, was measured with trypan blue. Statistical
analysis to determine LD50 was accomplished through the
PROBIT method.
RESULTS AND DISCUSSION
Thirty six plant extracts from the Brazilian Atlantic
Forest (Anadenanthera colubrina, Aparisthmium cordatum,
Apuleia leiocarpa, Astronium fraxinifolium, Bathysa
australis, Bombacopsis stenopetala, Brosimum guianense,
Cariniana estrellensis, Carpotroche brasiliensis, Casearia
sylvestris, Cedrela fissilis, Croton floribundus, Dalbergia
nigra, Ficus gomelleria, Guapira opposita, Guettarda
virburnoides, Luehea grandiflora, Mabea fistulifera,
Malouetia arborea, Melanoxylon brauna, Pera
heteranthera, Pera leandri, Peschiera affinis, Piptadenia
gonoacantha, Plathymenia foliolosa, Pouteria filipes,
Psychotria vellosiana, Senifeldera multiflora, Simira
glaziovii, Simira sampaioana, Siparuna guianensis,
Siparuna reginae, Sorocea bonplandii, Sparattosperma
leucanthum, Zanthoxylum rhoifolium, Virola oleifera) were
tested for their antimycobacterial activity at the
concentration of 100 µg/mL in order to select the most active
ones (Table I). Five extracts: Psychotria vellosiana;
Pouteria filipes, Cedrela fissilis, Plathymenia foliolosa and
Peschiera affinis were active against M. tuberculosis with
MIC between 0.2 and 3.12 µg/mL (Table II). Concerning M.
kansasii, three of these extracts (Cedrela fissilis,
Plathymenia foliolosa and Peschiera affinis) were also
active, however with MIC 100 µg/mL (Table II). Other ten
extracts were active only against M. kansasii: with MIC of
the 100 µg/mL (Siparuna arianeae (Siparunaceae);
Guettarda virburnoides (Rubiaceae); Cariniana estrellensis
(Lecythydaceae); Sparattosperma leucanthum
(Bignoniaceae); Brosimum guanense (Moraceae)),
50 µg/mL (Siparuna reginae (Siparunaceae); Piptadenia
gonoacantha (Fabaceae); Ficus gomelleria (Moraceae));
25 µg/mL (Aparisthmium cordatium (Euphorbiaceae)) and
1,56 µg/mL (Senifildera multiflora (Euphorbiaceae)). The
five extracts active against M. tuberculosis belong to plants
used in Brazilian Folk Medicine (1, 3, 10, 12). Even though
a larger number of extracts showed activity against M.
kansasii, in general, their MIC were higher than those for M.
tuberculosis (Table II). In fact, environment microorganisms
show a higher level of natural resistance than classical
pathogens.
The cytotoxicy of the five extracts active against M.
tuberculosis was evaluated showing that one (Peschiera
affinis) was not toxic to VERO cells in the concentration of
458 µg/mL (Figure 1). The extract of Peschiera affinis,
besides not being toxic for the VERO cells in a higher
concentration, also presented a low MIC against M.
tuberculosis.
The presence of indol alkaloids, commonly found in
plants of the families Rubiaceae and Apocynaceae
(Schripsema et al., 2003) could explain the activity of the
extracts of Psychotria vellosiana and Peschiera affinis
TABLE I - MIC of active extracts of the Atlantic forest against to M. tuberculosis and M. kansasii
Nº of the extracts with MIC of the (µg/mL)
0.20 0.78 1.56 3.12 25 50 100 >100*
M. tuberculosis 2 2 1 31
M. kansasii 1 1 3 8 23
* No active extract.
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against mycobacteria. Phytochemical analyses of plants of
the genus Psychotria demonstrated the presence of
psychotridines, which have been associated with dose-
dependent analgesic effects (Amador et al., 2001).
Peschiera affinis as well as other Apocynaceae plants are
used in northeast Brazil as antitumoral and spasmolytic
drugs (Miranda et al., 2003).
The family Maliaceae, represented in this study by
Cedrela fissilis presents modified triterpenes (limonoids)
and inhibitory activity has been demonstrated in the enzyme
Leishmania APRT (Adenine Phosphoribosyl Transferase),
present also in M. tuberculosis genome (Ambrozin et al.,
2005). This enzyme has an important function in the
pathway of purine salvation, which turns this enzyme an
interesting target to antimicrobial agents (Zottis et al.,
2006).
Recently, an extract of Plathymenia foliolosa
showed antimicrobial activity against E. coli (Alves, 2000),
allowing to infer that this plant could be active against other
microorganisms.
These results suggest that Peschiera affinis has
active compounds against M. tuberculosis and M. kansasii
which are not toxic to human cells. Further purification
studies on the extract of this plant are being carried out in
order to identify the active compounds.
RESUMO
Análise da atividade antimicobacteriana de 36 extra-
tos vegetais da Mata Atlântica brasileira
Trinta e seis extratos vegetais originários da Mata Atlân-
tica foram testados quanto à sua atividade
antimicobacteriana frente ao M. tuberculosis H37Rv e M.
kansasii, utilizando o método REMA em concentrações
seriadas de 100 a 0,20 µg/mL. Dentre os trinta e seis ex-
tratos testados, cinco mostraram atividade frente ao M.
tuberculosis, e destes apenas, três mostraram atividade ao
M. kansasii, que apresentou susceptibilidade a outros dez.
O teste de citotoxicidade com células VERO foi realizado
com os cinco extratos ativos frente ao M. tuberculosis em
que identificou-se a não toxicidade em apenas um extra-
to (Peschiera affinis) na concentração de 100 µg/mL.
UNITERMOS: Mycobacterium tuberculosis.
Mycobacterium kansasii. Extratos vegetais/atividade
antimicobacteriana. Antimicobacterianos. Citotoxicidade.
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